The endocannabinoid system and liver diseases.
Subject: Liver Disease - PUBLISHED VIA Journal of Neuroendocrinology
Author(s): View Source >>
Caraceni P, Domenicali M, Bernardi M
Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol.
Published via PLOS ONE
Published via European Journal of Pharmacology
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death.
Published via Author Manuscript
Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis.
Published via Cell Death & Disease
Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice.
Published via British Journal of Pharmacology